bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
businesswire.com
BIAFW
BIAF
The article highlights a new clinical framework for pulmonary nodule risk stratification and early lung cancer detection using the company's CyPath® Lung technology, indicating a positive development and potential market growth.